Ion Țiriac commented on the scandal that broke out in the ATP circuit after it was found out that Jannik Sinner, the Italian ranked 1st in the men’s world ranking, was caught doping twice in March with clostebol, an anabolic steroid derived from testosterone.
Ion Țiriac does not believe that Jannik Sinner had reasons to dope with clostebol: “He did not need doping”
After it was determined that Jannik Sinner had unintentionally contaminated himself with this banned substance, the Italian was exonerated and his suspension from the circuit was not ordered.
The Romanian businessman is of the opinion that Jannik Sinner would not have had any serious reason for using doping substances and believes that the player deserves his trust, as he believed in the case of Simona Halep , who tested positive for roxadustat and who served a nine-month suspension.
“Sinner…sir, I put my hand in the fire for Simona Halep. I’d put it in for Sinner too. He didn’t need doping. Sinner needs an athletics trainer to do his legs, as I got Frank Dick, the national athletics trainer of Great Britain, in Becker’s time.
I told Sinner since he was 15 years old, when I took him and said “that’s it”, and this is the public thing in Italy, everyone knows it, that if he doesn’t do his feet he has to take care .
It finishes much faster than it should. He is a great player and a good player and an Italian number 1 makes a lot of difference in world tennis”, said Ion Țiriac, in the online show ” Prietenii lui Ovidiu “.
The statement issued by ITIA regarding the doping case of Jannik Sinner
On August 20, ITIA sent an announcement informing that the ATP leader Jannik Sinner was detected positive for clostebol following two anti-doping tests carried out in March of this year, but also that the Italian was not suspended as a result of this thing, the international forum citing the fact that it is an accidental contamination and that one of the members of the athlete’s medical staff would be to blame for it.
Sinner provided an in-competition sample at Indian Wells on March 10, 2024, which contained the presence of a clostebol metabolite at low concentrations.
Another sample, taken out of competition eight days later, also tested positive for the same metabolite – again at low concentrations,” the ITIA reported
